Premium supply from leading manufacturers.
In stock — California warehouses.
Minimum order quantity: 25kg.
1.What is Vitamin D3(VD3)?
Vitamin D3, known as the "sunshine vitamin," is one member of the vitamin D family and is also called cholecalciferol.
As a vitamin-based medication, vitamin D3:
Promotes calcium absorption in the small intestinal mucosa
Increases blood calcium and phosphorus concentrations
| Items | Specifications | Results | Methods |
| Description | White to light yellow powder,no foreign objects visible,no foreign matter and no odor. |
Complies | Visual |
| Identification | The retention time of the principal peak conforms to which in the reference solution |
Complies | HPLC |
| Net Quantity | Should meet the requirements | Complies | / |
| Particle Size | 100%pass through sieve 40 mesh Min.90%pass through sieve 80 mesh |
100% 99.5% |
USP<786> Ph.Eur.2.9.12 |
| Vitamin D₃Assay | ≥100,000IU/g | 113,000IU/g | HPLC |
| Loss on drying | ≤5.0% | 4.2% | USP<731> Ph Eur.2.2.32 |
| Heavy Metals(as Pb) | ≤10.0ppm | Complies | USP<231>Ⅱ Ph.Eur.2.4.8 |
| Lead(as Pb) | ≤2.0ppm | <0.05ppm | USP<251> Ph.Eur.2.4.10 |
| Arsenic(as As) | ≤2.0ppm | <0.05ppm | USP<211>Ⅱ Ph.Eur.2.4.2 |
| *Cadmium(as Cd) | ≤1.0ppm | / | USP<233> |
| *Mercury(as Hg) | ≤0.1ppm | / | USP<233> |
| Total aerobic microbial count Total moulds and yeasts count |
≤1000CFU/g ≤100CFU/g |
<10CFU/g <10CFU/g |
USP<2021> Ph.Eur.2.6.12 |
| Enterobacterial | ≤10CFU/g | <10CFU/g | USP<2021> Ph.Eur.2.6.13 |
| *Escherichia coli *Salmonella *Staphylococcus aureus |
n.d/10g n.d./25g n.d/10g |
/ / / |
USP<2022> Ph Eur.2.6.13 |
| Conclusion:Conform to USP/EP | |||
| Remarks:1.Store in a sealed,dark,and dry place(recommended storage temperat re Lelow 25℃). 2.*It is a type inspection project,and it should be tested at least once a vezr 3.The products in this report are in compliance with export health stand;ndiand are for export use only! |
|||
2.Benefits and Use
Primary indications for preventing and treating skeletal disorders caused by vitamin D deficiency include:
Prevention and treatment of osteoporosis in postmenopausal women and the elderly (manifested as reduced bone density and increased fracture risk).
Management of acute/chronic tetany (characterized by involuntary muscle spasms in hands/feet), including perioperative or idiopathic cases.
Treatment of hypoparathyroidism (e.g., post-surgical or idiopathic parathyroid hormone deficiency).
Correction of chronic conditions:
Hypocalcemia (persistently low blood calcium)
Hypophosphatemia (inadequate blood phosphorus)
Rickets (pediatric bone softening/deformities)
Osteomalacia associated with chronic kidney disease
Hereditary hypophosphatemia
As foundational therapy combined with other treatments for nutritional vitamin D deficiency:
Childhood rickets (bone softening/deformities)
Adult osteomalacia (impaired bone mineralization)
3.Q&A
Q:Does the company accept sample orders?
A:Yes, our company accepts sample orders.
Q:What is the minimum order quantity for the company?
A:We do not have a minimum order quantity requirement, we arrange according to the customer's needs.
Q:How to ensure the quality of goods?
A:We have a strict QC/QA management system and strict release procedures, and we will provide all procedures to customers before shipment according to their requirements.
Q:Can we see the product quality before the order is shipped?
A:Of course, we always provide a relative Batach (s) 'COA before shipping.
Q:How will you deliver the goods?
A:We will communicate with customers, adopt their suggestions, arrange the most suitable delivery method, and ensure mutual satisfaction.
Arshine Lifescience Inc.,
Your Trusted Ingredient Partner.
Add.: Ontario, California, USA
Email: info@arshineusa.com
WhatsApp: 16576561162
EN